Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03916692 · ClinicalTrials.gov registry record · NA
GRAPE • Glycemic Response of Amylopectin Containing Drinks
A NA study, sponsored by Arizona State University.
- Terminated
- Registry status
- NA
- Development phase
- 15
- Enrollment target
NCT03916692 is a NA study that was terminated before completion, run by Arizona State University. The registered enrollment target is 15 participants.
The verdict
NCT03916692, a NA study, was terminated before completion, sponsored by Arizona State University.
- TERMINATED
- Registry status
- NA
- Development phase
- 15 participants
- Enrollment target
Study Summary
To quantify the glycemic index of the SP energy-smart-based nutrition supplement and the SP Glucose-support formula as compared to a glucose drink. We hypothesized that both the energy-smart-based nutritional supplement and the SP Glucose-support formula will have low glycemic index. The aim of the study is to quantify the glycemic index of the SP energy-smart-based nutrition supplement and the SP Glucose-support formula as compared to a glucose drink. We hypothesized that both the energy-smart-based nutritional supplement and the SP Glucose-support formula will have low glycemic index.
Interventions
- DIETARY_SUPPLEMENT Carbohydrate drink
- DIETARY_SUPPLEMENT Energy smart Carbohydrate blend
- DIETARY_SUPPLEMENT Liquid Dextrose
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2019-04-23 |
| Est. Completion | 2021-08-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03916692
The ClinicalTrials.gov registry entry for NCT03916692 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 15 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Arizona State University, which has 187 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Carbohydrate drink is the first listed.
NCT03916692 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03916692 about?
NCT03916692 is a clinical study titled "GRAPE • Glycemic Response of Amylopectin Containing Drinks". To quantify the glycemic index of the SP energy-smart-based nutrition supplement and the SP Glucose-support formula as compared to a glucose drink. We hypothesized that both the energy-smart-based nutritional supplement and the SP Glucose-support formula will have low glycemic index. The aim of the...
What is the current status of trial NCT03916692?
This trial is currently terminated. It is a NA study. The enrollment target is 15 participants. The study started on 2019-04-23. Estimated completion is 2021-08-30.
What interventions are being tested in trial NCT03916692?
The interventions under investigation include: Carbohydrate drink (DIETARY_SUPPLEMENT), Energy smart Carbohydrate blend (DIETARY_SUPPLEMENT), Liquid Dextrose (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT03916692?
This trial is sponsored by Arizona State University, which has 187 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.